Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Carcinoma (CRC) Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05813028
What this trial is testing

The Effect of a Mobile Application on Patient Outcomes in Colorectal Cancer Patients

Who this might be right for
Colorectal CancerNursing
Ankara University 100
Not applicableUnknownNCT03254836
What this trial is testing

Sleep and Survival in Colorectal Cancer

Who this might be right for
Colorectal NeoplasmCircadian Rhythm Sleep DisorderDepression+2 more
Zealand University Hospital 45
Testing effectiveness (Phase 2)Study completedNCT02414009
What this trial is testing

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 82
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Not applicableUnknownNCT05131243
What this trial is testing

The Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IIColorectal Cancer Stage III
Fujian Cancer Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT07219238
What this trial is testing

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Who this might be right for
Colorectal CancerGastric CancersOvarian Cancers+1 more
GE Healthcare 175
Testing effectiveness (Phase 2)Study completedNCT03271047
What this trial is testing

Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation

Who this might be right for
MSSRAS-mutant Colorectal Cancer
Pfizer 75
Large-scale testing (Phase 3)Study completedNCT00352638
What this trial is testing

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fox Chase Cancer Center 660
Not applicableStudy completedNCT04880772
What this trial is testing

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

Who this might be right for
Cancer of ColonCancer of RectumLiver Metastases
East Lancashire Hospitals NHS Trust 42
Early research (Phase 1)UnknownNCT01157052
What this trial is testing

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

Who this might be right for
Neoplasms, ColorectalColorectal CancerColorectal Carcinoma
AHS Cancer Control Alberta 15
Large-scale testing (Phase 3)Study completedNCT00004252
What this trial is testing

Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00310076
What this trial is testing

Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer

Who this might be right for
Carcinoma of the AppendixColorectal Cancer
Wake Forest University Health Sciences 29
Early research (Phase 1)Active Not RecruitingNCT02817633
What this trial is testing

TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Who this might be right for
Neoplasms
Tesaro, Inc. 463
Not applicableStudy completedNCT04594655
What this trial is testing

MPI Predicts Outcome of CRC Elderly Patients (MPI=MULTIDIMENSIONAL PROGNOSTIC INDEX; CRC=COLORECTAL CANCER)

Who this might be right for
Colorectal CancerFragilityElderly
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 104
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07358585
What this trial is testing

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer Adenocarcinoma
Shanghai Henlius Biotech 126
Not applicableUnknownNCT05958433
What this trial is testing

Preoperative Rehabilitation With Stoma Appliance in Colorectal Cancer Patients

Who this might be right for
Rehabilitation
Assiut University 170
Testing effectiveness (Phase 2)Study completedNCT01281761
What this trial is testing

Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)

Who this might be right for
Metastatic Colorectal Cancer
Samsung Medical Center 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446270
What this trial is testing

Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal Malignancies

Who this might be right for
Treatment for Advanced Colorectal CancerTreatment for Advanced Pancreatic Cancer
Chinese PLA General Hospital 90
Not applicableUnknownNCT05039060
What this trial is testing

Modified MAC Diet and Gut Microbiota in CRC Patients

Who this might be right for
Colorectal CancerGut MicrobiotaDiet Intervention
Korea University Anam Hospital 40
Not applicableStudy completedNCT01959269
What this trial is testing

Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy

Who this might be right for
Colorectal Neoplasm
Bayer 483
Next Page